Alzheimer’s Research UK (ARUK) is the UK’s leading dementia research charity working to understand and treat the diseases that cause dementia. ARUK has partnered with world leading pharmaceutical companies to form the Dementia Consortium to co-fund research projects in dementia.
The Dementia Consortium is currently seeking innovative target-based research proposals from academic scientists worldwide that aim to validate novel targets for the diseases that cause dementia and with industry support, progress targets to early drug discovery. The most promising targets may progress to pre-clinical and clinical studies. Applications will include an identified novel target with preliminary evidence to support a role for the target in dementia. The approaches considered can cover all aspects of dementia therapy, from treating the underlying pathology to improving cognition and other mental symptoms.